Valuation

Kymera Therapeutics, Inc. Valuation

Valuation for Kymera Therapeutics, Inc. (KYMR) on 6ix covers company data, market context, news, risks, and AI research briefs.

websiteKYMRValuation/analysis/KYMR/valuation

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to KYMR.

Stock profile

Ticker

KYMR

Asset type

Stock

Market cap

$7.44B

Sector

Health Technology

Industry

Biotechnology

Currency

USD

Ticker listings

Kymera Therapeutics, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.

  • KYMR primary listing

Research sections

Valuation

Review valuation context for Kymera Therapeutics, Inc..

Future growth

Review future growth context for Kymera Therapeutics, Inc..

Past performance

Review past performance context for Kymera Therapeutics, Inc..

Financial health

Review financial health context for Kymera Therapeutics, Inc..

Dividend

Review dividend context for Kymera Therapeutics, Inc..

Management

Review management context for Kymera Therapeutics, Inc..

Ownership

Review ownership context for Kymera Therapeutics, Inc..

Other information

Review other information context for Kymera Therapeutics, Inc..

Community

Review community context for Kymera Therapeutics, Inc..